LCAT and cardiovascular disorder: Given its major role in both LDL and HDL metabolism, LCAT modulation therapies have been the subject of active investigation for preventing cardiovascular disease (13, 14) as well as potentially treating lipoprotein-X-induced kidney problems in LCAT deficient subjects (15, 16).